Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsAspirus Arise Part D Transition Policy Coverage | …
    Ask Trek AI about this page
    CurrentAspirus ArisePolicy N/A

    Medicare Part D Prescription Drug Transition Policy

    Customize your policy alerts

    Sign up for all Aspirus Arise policy alerts

    Know when Aspirus Arise releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines Aspirus Health Plan's temporary prescription refill (transition) process for Part D drugs for new members, members experiencing formulary changes, and long-term care residents, including emergency supply and extension rules.

    Policy Summary
    PayerAspirus Arise
    PolicyMedicare Part D Prescription Drug Transition Policy
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective Date
    Next Review Date
    Key ActionSend written notice to members within three business days of the transition fill explaining the temporary nature of the supply, how to work with providers to find alternatives, and how to request a formulary exception.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    30minimum retail transition supply
    31minimum LTC/emergency transition supply

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    90
    transition eligibility window (days)

    Medicare Part D Transition Coverage Criteria

    General Transition Eligibility (retail setting)

    Provide temporary supply of non-formulary Part D drugs when ALL of the following apply:

    ALL of the following

    • Member is a new enrollee in Aspirus Health Plan within the first 90 days of eligibility
    • Or current member who is taking medication(s) no longer covered or subject to new formulary restrictions within the first 90 days of the new contract year

      This includes Part D drugs on formulary that require prior authorization or step therapy.

    Transition supply — retail

    When eligible in retail setting:

    ALL of the following

    • Provide temporary supply of non-formulary Part D drugs for at least 30 days

      Unless the prescription is written for less than 30 days.

    • Applies to Part D drugs that are on the formulary but require prior authorization or step therapy

    Transition Eligibility (long-term care setting)

    Provide temporary supply in LTC when ALL of the following apply:

    ALL of the following

    • Member is a new enrollee in Aspirus Health Plan within the first 90 days of eligibility
    • Or current member living in long-term care facility who is taking medication(s) no longer covered or subject to new formulary restrictions within the first 90 days of the new contract year

      Includes Part D drugs that require prior authorization or step therapy.

    Transition supply — long-term care and emergency supply

    When eligible in LTC or during an emergency while exception is processed:

    ALL of the following

    • Provide temporary or emergency supply of non-formulary Part D drugs for at least 31 days

      Unless prescription is written for less than 31 days.

    • Honor multiple fills as necessary to provide up to a 31-day supply
    • If member is outside the 90-day transition period, an emergency supply will still be provided while an exception is being processed

    Level of care changes

    Transition process also applies when ALL of the following occur:

    ALL of the following

    • Member has a level of care change such as admission to or discharge from a long-term care facility or other institution
    • Discharge planning is completed before the member is discharged

      Notices that a refill is 'too soon' will be waived to prevent delays.

    Transition extension

    When the exception request or appeal is not decided by the end of the minimum transition period, Aspirus may extend the transition on a case-by-case basis. The extension ends when ANY of the following occur:

    ANY of the following

    • The medication is changed to another formulary drug
    • The exception request or appeal is decided

    Transition Timeframes and Minimum Supplies

    Minimum transition supply and eligibility thresholds
    Retail minimum supply>= 30 days
    Long-term care minimum/emergency supply>= 31 days
    Transition eligibility window<= 90 days from enrollment or contract year change
    30Minimum retail transition supply (days)
    31Minimum LTC / emergency transition supply (days)
    90Transition eligibility window (days)

    Actions, Notices, and Prior Authorization

    Documentation Required

    Notices to member

    Aspirus Health Plan will send written notice to members within three business days of the transition fill, stating the transition supply is temporary, explaining how to work with the provider to find another medication that may be available and appropriate, and explaining the member’s right and instructions to request a formulary exception.

    Prior Authorization

    Exception/appeal processing and extension

    If an exception request or appeal is pending at the end of the minimum transition period, providers or members may request a transition extension by contacting Aspirus Health Plan Medicare Advantage Plans Customer Service; the plan will extend the transition on a case-by-case basis until the exception or appeal is decided or the medication is changed.

    Policy Background and Purpose

    This policy implements the Medicare Part D transition requirement to provide members with a temporary supply of medications when they cannot obtain their drugs due to enrollment, formulary changes, or level-of-care changes. The intent is to ensure continuity of therapy while prior authorizations, exceptions, or appeals are processed and a longer-term coverage decision is made. Examples of covered situations include new enrollees within the first 90 days of eligibility, members affected by formulary changes early in the contract year, and residents of long-term care facilities who require immediate access to non-formulary Part D drugs or drugs subject to prior authorization or step therapy.

    Aspirus Health Plan will provide a temporary retail supply for at least 30 days (unless the prescription is written for less than 30 days) and a temporary long-term care or emergency supply for at least 31 days (unless the prescription is written for less than 31 days). In the long-term care setting, multiple fills may be honored as needed to provide up to a 31-day supply. If an exception or appeal remains pending at the end of the minimum transition period, the plan may extend the transition on a case-by-case basis until the exception/appeal is decided or the medication is changed to a formulary alternative.

    Certain drugs may not qualify for transition and could require a coverage determination before transition is allowed (for example, excluded Medicare drugs, over-the-counter products, weight-loss or cosmetic drugs, drugs requiring a Part B vs Part D determination, or drugs prescribed for non-approved indications). The plan will send written notice to members within three business days of a transition fill explaining the temporary nature of the supply, how to work with their provider to find alternatives, and instructions to request a formulary exception.

    Defined Terms

    Definitions
    Transition supplyA temporary fill of a Part D drug provided when a member cannot obtain their medication due to enrollment or formulary changes, typically for 30 days (retail) or 31 days (LTC).
    Long-term care (LTC) settingIncludes members residing in long-term care facilities; LTC transition rules allow multiple fills to cover up to a 31-day supply and emergency supplies while exceptions are processed.
    Policy Summary
    PayerAspirus Arise
    PolicyMedicare Part D Prescription Drug Transition Policy
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective Date
    Next Review Date
    Key ActionSend written notice to members within three business days of the transition fill explaining the temporary nature of the supply, how to work with providers to find alternatives, and how to request a formulary exception.
    SourceLink
    On This Page
    Medicare Part D Transition Coverage CriteriaTransition Timeframes and Minimum SuppliesActions, Notices, and Prior AuthorizationPolicy Background and PurposeDefined Terms
    Denial Risk

    Excluded drugs from transition

    Certain drugs may not qualify for the Part D transition and may require a coverage determination before transition is allowed. Examples include excluded Medicare drugs, over-the-counter (OTC) products, weight-loss or cosmetic drugs, drugs requiring a Part B vs Part D coverage determination, and Medicare-covered drugs prescribed for a non‑approved indication.